# US 2012/0252764 A1 · Compositions and methods for protecting cells from toxic exposures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252764 A1
- Document ID: US20120252764A1
- Status: Published application
- Kind: A1
- Application number: 13/469,984
- Filed: 2012-05-11
- Published: 2012-10-04
- Earliest claimed: 2007-03-27
- Assignees: Perscitus Biosciences, LLC
- Inventors: James P. Thomas
- Web page: https://patentgrep.com/patent/US20120252764A1

## CPC

- A61K 31/66: Phosphorus compounds
- A61K 41/00: Medicinal preparations obtained by treating materials with wave energy or particle radiation {; Therapies using these preparations}
- A61P 39/06: Free radical scavengers or antioxidants
- C07F 9/1651: {with hydroxyalkyl compounds with further substituents on alkyl}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The present invention provides compositions and methods for protecting cells and tissues from damage associated with therapeutic treatments of cancers and other diseases and conditions where reactive oxygen species are produced. The present invention also provides compositions useful as research reagents.

## Claims

### Claim 1

A composition comprising Formula I.

### Claim 2 (depends on 1)

The composition of claim 1, wherein R1 and R2 groups are ethyl groups.

### Claim 3 (depends on 1)

The composition of claim 1, wherein n is 2.

### Claim 4 (depends on 1)

The composition of claim 1, wherein R1 and R2 groups are ethyl groups and wherein n is 2.

### Claim 5 (depends on 1)

The composition of claim 1, wherein Formula I further comprises a monosodium salt of the phosphorothioate group.

### Claim 6

A composition comprising 2-amino-4-(1-ethoxycarbonyl-2-phosphonosulfanyl-ethylcarbamoyl)-butyric acid ethyl ester monosodium salt.

### Claim 7

A method for protecting cells from the toxic effects of free radical generating therapies comprising:
a) providing a subject with a condition being treated with therapies that are toxic to normal cells and disease cells,
b) co-administering to said subject: a) said toxic therapy and, b) a therapeutic agent, that through metabolism in said subject, causes accumulation of a chemoprotectant compound in said normal cells at a higher concentration than in said disease cells.

### Claim 8 (depends on 7)

The method of claim 7, wherein said chemoprotectant compound comprises glutathione.

### Claim 9 (depends on 7)

The method of claim 7, wherein said disease cells comprise cancer cells.

### Claim 10 (depends on 7)

The method of claim 7, wherein said toxic therapy comprises administration of an anti-cancer chemotherapy.

### Claim 11 (depends on 7)

The method of claim 7, wherein said toxic therapy comprises administration of radiation.
